Diabetes-Periodontitis Interrelationship Dynamics

The interrelationship between diabetes and periodontitis is characterised by a bidirectional influence in which chronic hyperglycaemia exacerbates periodontal inflammation and tissue destruction, while persistent oral infection and inflammation contribute to impaired glycaemic control. Hyperglycaemia promotes advanced glycation end-product formation, oxidative stress and dysregulated immune responses within the periodontium, leading to enhanced activation of pro-inflammatory pathways, vascular dysfunction and osteoclastogenesis. Conversely, periodontal pathogens and their virulence factors induce systemic inflammation, heighten insulin resistance and impair pancreatic β-cell function. Clinical interventions such as intensive periodontal therapy have been shown to improve markers of glycaemic control, and systemic glucose-lowering agents may confer protective effects on periodontal tissues. This dynamic underscores the importance of integrated oral-systemic management strategies in reducing the global burden of both conditions.

Research from Nature Portfolio

Seminal work has identified osteoblast-lineage cells as active participants in periodontitis, demonstrating that activation of the NF-κB pathway within osteoblasts upregulates RANKL expression, drives osteoclastogenesis and precipitates alveolar bone loss. Transgenic models with impaired NF-κB signalling in bone-forming cells are protected from bacteria-induced periodontal destruction, highlighting a bone-cell-centric mechanism in disease progression. In parallel, bioactive flavonoids such as quercitrin have been shown to attenuate inflammation and promote both soft-tissue and bone regeneration. In vitro studies reveal that quercitrin downregulates pro-inflammatory mediators in gingival fibroblasts and enhances osteoblastic differentiation of mesenchymal stem cells, suggesting potential for adjunctive regenerative therapies.

Diabetes-Periodontitis Interrelationship Dynamics publication trend

The graph below shows the total number of articles in diabetes-periodontitis interrelationship dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Dysbiosis: A pathological imbalance in the composition or function of the microbial community in the oral cavity.

Hyperglycaemia: A state of elevated blood glucose concentrations that can disrupt cellular and vascular homeostasis.

Insulin resistance: A condition in which target tissues such as liver, muscle and adipose exhibit reduced responsiveness to insulin signalling, leading to impaired glucose uptake and metabolism.

NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells): A transcription factor complex that regulates genes involved in inflammation, immunity and cell survival.

RANKL (receptor activator of NF-κB ligand): A cytokine produced by osteoblast-lineage and immune cells that binds to RANK on osteoclast precursors to initiate bone resorption.

References

1. Periodontitis as a promoting factor of T2D: current evidence and mechanisms. International Journal of Oral Science (2023).
2. Repurposing Metformin for periodontal disease management as a form of oral-systemic preventive medicine. Journal of Translational Medicine (2023).
3. Osteoblast Lineage Cells Play an Essential Role in Periodontal Bone Loss Through Activation of Nuclear Factor-Kappa B. Scientific Reports (2015).
4. Quercitrin for periodontal regeneration: effects on human gingival fibroblasts and mesenchymal stem cells. Scientific Reports (2015).